The Immortal Life of Henrietta Lacks
Description:
In 1951, a young woman from Baltimore died of cancer. Her death changed medical science for ever. Her name was Henrietta Lacks, but scientists know her as HeLa. She was a poor Southern tobacco farmer whose cancer cells - taken without her knowledge - became one of the most important tools in medicine. The first 'immortal' human tissue grown in culture, HeLa cells were vital for developing the polio vaccine; uncovered secrets of cancer, viruses, and the effects of the atom bomb; helped lead to important advances like in vitro fertilization, cloning, and gene mapping; and have been bought and sold by the billions. Yet Henrietta herself remains virtually unknown, buried in an unmarked grave. Now Rebecca Skloot takes us on an extraordinary journey in search of Henrietta's story, from the 'coloured' ward of Johns Hopkins Hospital in the 1950s to East Baltimore today, where her children and grandchildren live, and struggle with the legacy of her cells. Full of warmth and questing intelligence, astonishing in scope and impossible to put down, "The Immortal Life of Henrietta Lacks" captures the beauty and drama of scientific discovery, as well as its human consequences.
Best prices to buy, sell, or rent ISBN 9780230750210
Frequently Asked Questions about The Immortal Life of Henrietta Lacks
The price for the book starts from $15.96 on Amazon and is available from 3 sellers at the moment.
If you’re interested in selling back the The Immortal Life of Henrietta Lacks book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the The Immortal Life of Henrietta Lacks book, the best buyback offer comes from and is $ for the book in good condition.
The The Immortal Life of Henrietta Lacks book is in very low demand now as the rank for the book is 7,778,215 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.